Mrs. Johnson takes her blood pressure at her kitchen table on a Tuesday morning. She doesn't call anyone. She doesn't drive anywhere. She doesn't even think about it — she just wraps the cuff around her arm the way she does every morning and presses the button.

Twelve seconds later, that reading transmits over a cellular network to a dashboard I'm watching from my home office in rural Pennsylvania. I see the number before her physician does. Before her family does. Before she even writes it down — if she writes it down at all.

Her systolic has been creeping up for three days. Not dramatically. Not enough to send her to the ER. But enough for me to pick up the phone and ask how she's been feeling, whether she's been taking her lisinopril consistently, whether anything changed in her diet this week.

That conversation takes seven minutes. It prevents a crisis that would have taken seven days to surface in a traditional care model — and possibly a hospital admission to resolve.That's care management in 2026. And most people have no idea it's happening.

The Gap Nobody Talks About

Here's what the healthcare system looks like right now for a Medicare patient with three or four chronic conditions:

They see their physician twice a year for 15 minutes. They pick up their prescriptions — if they still have a pharmacy nearby. And in between those two touchpoints, they're on their own. Managing medications they don't fully understand. Monitoring symptoms they can't interpret. Making daily decisions about diet, exercise, and adherence with no clinical guidance whatsoever.

More than 50 million Americans now live in what researchers call "pharmacy deserts" — communities where the nearest pharmacy is 10 or more miles away. Over 10,000 pharmacies have closed since 2020. The nursing home staffing mandate requiring a registered nurse on site 24/7 was repealed as of February 2026. Legislation is actively pushing patients out of long-term care facilities and into aging-in-place models at home.

The patients didn't get healthier. They just lost the infrastructure around them.

And the research is clear about what happens when pharmacist oversight disappears: the annual cost of drug-related morbidity and mortality in nursing facilities without consultant pharmacist services is $7.6 billion — nearly double the $4 billion cost when pharmacists are involved. For every dollar spent on drugs in those settings, $1.33 is consumed treating drug-related problems. Pharmacist-led medication management returns $2.10 to $2.60 for every dollar invested.

The outcomes aren't debatable. The question is whether we're going to build the model to deliver those outcomes where patients actually are — which is increasingly at home.

What the Infrastructure Actually Looks Like

When I explain what I do to people outside of healthcare, they picture a pharmacist behind a counter. When I explain it to people inside healthcare, they picture a billing code.

Neither picture is complete.

Care management — specifically Remote Patient Monitoring and Chronic Care Management — is an infrastructure. It has layers. And every layer matters.

The first layer is the device. A blood pressure cuff, a scale, a glucometer, a pulse oximeter — sitting in a patient's home, collecting data every single day. Not consumer-grade gadgets from Amazon. Clinical-grade, validated devices that produce data a clinician can actually act on.

This matters more than most people realize. If the device isn't accurate, the data is noise. If the data is noise, the clinician can't trust it. And if the clinician can't trust it, the whole model falls apart.

That's why it caught my attention when the American Medical Association added the Prevounce Pylo 900-LTE blood pressure monitor to their Validated Device Listing. The AMA's VDL is an independent, rigorous evaluation — no manufacturer funding, no industry influence. An independent review committee examines the clinical validation testing documentation and determines whether the device meets their accuracy criteria. Only 154 blood pressure devices in the country are on that list.

The Pylo 900-LTE is one of them. It's the device platform I use in my practice. And here's why it matters for the model: It connects over cellular networks — 5G, 4G LTE, with 2G fallback. That means it works in rural Pennsylvania, where half my patients live. No WiFi setup. No Bluetooth pairing. No tech support calls from an 82-year-old trying to connect to their router. The patient presses a button. The reading transmits. I see it.

It has a triple measurement mode that automatically takes three sequential readings to align with the latest American Heart Association blood pressure guidelines. That's not a convenience feature. That's clinical rigor built into the hardware.

And it was recently cleared by the FDA for monitoring gestational hypertension during pregnancy — which means the same device infrastructure supporting my Medicare patients can also support maternal health programs. One platform. Multiple clinical applications.

The second layer is the software — the dashboard that aggregates patient readings, flags abnormalities, and creates the documentation trail that supports billing. I use the Prevounce platform for this. It turns raw data into clinical intelligence.

The third layer — and this is the one nobody talks about — is the clinician. The pharmacist who looks at the data, understands the medication regimen, recognizes the patterns, and makes the call.

A device without a clinician is just a gadget. A billing code without clinical judgment is just paperwork. The model works because all three layers work together: validated devices generating trustworthy data, software organizing it into actionable insights, and a pharmacist who knows what a three-day upward trend in blood pressure means for a patient on amlodipine, metformin, and lisinopril.

Why This Matters Right Now

I've been building this model for eight years across 19 physician partnerships in rural Pennsylvania. My team monitors over 200 Medicare patients using exactly this infrastructure — devices in their homes, data on our screens, clinical conversations every month.

We caught a 20-pound weight gain in 8 days on a heart failure patient. Not because she called us. Because her scale transmitted the data and we saw the trend before it became an emergency.

We've reduced hospital readmissions. We've improved medication adherence. We've given physicians a clinical partner who watches their patients between visits — not for 15 minutes twice a year, but every single day.

And the economics work. Medicare reimburses RPM and CCM services through existing billing codes. Physicians get a revenue stream. Patients get better care. Pharmacists get to practice at the top of their clinical training. The billing infrastructure already exists. The clinical evidence supports it. The devices are now AMA-validated.The model is no longer theoretical. It's operational. It's proven. And the need for it is growing every day as patients move out of facilities and into their homes.

The Piece That's Still Missing

There are approximately 340,000 pharmacists in the United States. Tens of thousands have been displaced by pharmacy closures. Thousands more face uncertainty as long-term care facilities downsize and the traditional LTC consultant role contracts.

Meanwhile, 27 million Americans will need long-term care services by 2050 — most of them at home. The gap between what patients need and what anyone is providing between physician visits is enormous. And it's growing.

The infrastructure to close that gap exists. The devices are validated. The billing codes are active. The outcomes are published. The clinical expertise lives inside every pharmacist who spent six years learning how medications work in the human body.

The only thing missing is the pharmacist willing to build it.

I built mine from a small town with no business degree, no MBA, and no one handing me a playbook. I teach other pharmacists how to build theirs. Some of them are reading this right now.

If you're a pharmacist watching the profession shift around you — the store closures, the staffing repeals, the legislative changes — know that the patients didn't disappear. They went home. And they need you there.The infrastructure is ready. The question is whether you are.

Dr. Thea M. Blystone, PharmD, is the founder of Tendco Health and TM Pharmacy Consulting. She writes weekly about the future of pharmacy consulting on Substack: The Full Prescription.

The devices and platform referenced in this article are from Prevounce Health and Pylo Health. Dr. Blystone uses these tools in her clinical practice and is sharing her experience. This is not a sponsored post.